Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The AGM in Hofseth BioCare ASA were held in Havnegata 11, Ålesund today on Monday 25 May 2020. All the matters were decided according to the proposals in the notice. Please find the minutes from the...
-
Ola Holen, Chairman of the Board of Hofseth BioCare ASA, has in connection to the upcoming Annual General Meeting on 25 May 2020, received proxy rights from shareholders representing 158 596 305...
-
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 ...
-
HBC had operating revenues of NOK 18.5m (NOK 14.7m) in the first quarter of 2020. Cost of Goods Sold (CoGS) amounted to NOK 6.2m (NOK 10.9m) in the period. Operational profit (EBITDA) for the first...
-
Hofseth BioCare ASA (“HBC”) recently filed a US patent application (630063274 04/07/2020) on minor components in OmeGo® salmon oil that significantly attenuate respiratory eosinophilic inflammation,...
-
Hofseth BioCare ASA (“HBC”) has signed a two-year research agreement with Stanford University School of Medicine, CA, USA to further investigate the gastro-intestinal (GI)-protective properties of...
-
The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Havnegata 11, 6005 Ålesund, on 25 May 2020 at 11:00 CET. All shareholders are encouraged to submit a voting...
-
Reference is made to the private placement of 3,253,370 new shares towards Bomi Framroze (the "Private Placement") in Hofseth BioCare ASA, as announced on 23 March 2020. The share capital increase...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE...
-
Styret i Hofseth BioCare ASA har i dag 20. mars 2020 godkjent årsrapporten for 2019. Årsrapporten inkludert ESG-rapport (kapittel 5) for 2019 ligger vedlagt. For ytterligere informasjon, vennligst...